XML 62 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
INTANGIBLE ASSETS (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross $ 9,625,938   $ 9,625,938   $ 9,625,938
Less: accumulated amortization (5,360,190)   (5,360,190)   (5,003,503)
Intangible assets, net 4,265,748   4,265,748   4,622,435
Amortization expense 119,763 206,454 356,687 612,632  
Future aggregate amortization expense for intangible assets [Abstract]          
2012 (Three months) 119,763   119,763    
2013 475,148   475,148    
2014 475,148   475,148    
2015 475,148   475,148    
2016 476,450   476,450    
2017 & Beyond 2,244,091   2,244,091    
Total 4,265,748   4,265,748    
Patents [Member] | Amlexanox (Aphthasol) [Member]
         
Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross 2,090,000   2,090,000   2,090,000
Patents [Member] | Amlexanox (OraDiscA) [Member]
         
Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross 6,873,080   6,873,080   6,873,080
Patents [Member] | OraDisc [Member]
         
Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross 73,000   73,000   73,000
Patents [Member] | Hydrogel nanoparticle aggregate [Member]
         
Finite-Lived Intangible Assets [Line Items]          
Intangible assets, gross $ 589,858   $ 589,858   $ 589,858